SMPD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.10889988700092E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.77640000043056E-07 |
Normal-vs-Stage2 |
8.517600E-03 |
Normal-vs-Stage3 |
8.50799997120788E-09 |
Normal-vs-Stage4 |
1.16620002543755E-09 |
Stage1-vs-Stage2 |
7.090000E-01 |
Stage1-vs-Stage3 |
5.770300E-02 |
Stage1-vs-Stage4 |
6.304500E-03 |
Stage2-vs-Stage3 |
1.226600E-01 |
Stage2-vs-Stage4 |
3.839800E-02 |
Stage3-vs-Stage4 |
4.648400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.39060000181601E-08 |
Normal-vs-AfricanAmerican |
9.55229995103224E-09 |
Normal-vs-Asian |
2.939900E-02 |
Caucasian-vs-AfricanAmerican |
8.043100E-04 |
Caucasian-vs-Asian |
3.779900E-02 |
AfricanAmerican-vs-Asian |
5.503600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.02169999963253E-07 |
Normal-vs-Female |
3.28659321979785E-12 |
Male-vs-Female |
8.953900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.743500E-03 |
Normal-vs-Age(41-60Yrs) |
4.8749999592701E-09 |
Normal-vs-Age(61-80Yrs) |
2.26850005446977E-09 |
Normal-vs-Age(81-100Yrs) |
4.039600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.943800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.261400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.285000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.978600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.132200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.272800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.59439999997724E-07 |
Normal-vs-Grade 2 |
5.40429999640324E-08 |
Normal-vs-Grade 3 |
1.34999999956698E-07 |
Normal-vs-Grade 4 |
7.38820005175E-10 |
Grade 1-vs-Grade 2 |
9.276500E-03 |
Grade 1-vs-Grade 3 |
7.655800E-03 |
Grade 1-vs-Grade 4 |
5.894800E-01 |
Grade 2-vs-Grade 3 |
8.692000E-01 |
Grade 2-vs-Grade 4 |
9.557800E-03 |
Grade 3-vs-Grade 4 |
6.521000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.89530000005433E-06 |
Normal-vs-ccB subtype |
8.94989999999929E-07 |
ccA subtype-vs-ccB subtype |
6.390000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.22070000166497E-08 |
Normal-vs-N1 |
1.22440000360768E-08 |
N0-vs-N1 |
2.607900E-02 |
|
|